CORC

在结果中检索

CORC

浏览/检索结果: 共79条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Haplotype-resolved genome assembly provides insights into evolutionary history of the tea plant Camellia sinensis 期刊论文
NATURE GENETICS, 2021, 卷号: 53, 期号: 8, 页码: 1250-+
作者:  Zhang, Xingtan;  Chen, Shuai;  Shi, Longqing;  Gong, Daping;  Zhang, Shengcheng
收藏  |  浏览/下载：52/0  |  提交时间：2021/09/08
天琴计划简介 期刊论文
中山大学学报(自然科学版)/Acta Scientiarum Naturalium Universitatis Sunyatseni, 2021, 卷号: 60, 期号: 1-2, 页码: 1-19
作者:  罗俊;  艾凌皓;  艾艳丽;  安子聪;  白伟钢
收藏  |  浏览/下载：144/0  |  提交时间：2021/01/18
Fabrication and Test of Diameter 35 mm Iron-Based Superconductor Coils 期刊论文
IEEE TRANSACTIONS ON APPLIED SUPERCONDUCTIVITY, 2020, 卷号: 30
作者:  Zhang, Zhan;  Wang, Dongliang;  Liu, Fang;  Jiange, Donghui;  Wei, Shaoqing
收藏  |  浏览/下载：82/0  |  提交时间：2020/11/26
Sulfonium, an Underestimated Moiety for Structural Modification, Alters the Antibacterial Profile of Vancomycin Against Multidrug-Resistant Bacteria 期刊论文
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2019, 卷号: 58, 期号: 20, 页码: 6678-6682
作者:  Guan, Dongliang;  Chen, Feifei;  Qiu, Yunguang;  Jiang, Bofeng;  Gong, Likun
收藏  |  浏览/下载：17/0  |  提交时间：2020/07/01
一类铒离子掺杂的硅酸盐晶体及其5微米波段激光器件 专利
专利号: CN109428257A, 申请日期: 2019-03-05, 公开日期: 2019-03-05
作者:  龚国亮;  陈雨金;  黄艺东;  林炎富;  黄建华
收藏  |  浏览/下载：19/0  |  提交时间：2019/12/30
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 期刊论文
JOURNAL OF HEPATOLOGY, 2019, 卷号: 70
作者:  Gong, Guozhong;  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun
收藏  |  浏览/下载：61/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：48/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：40/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：33/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace